Literature DB >> 12752399

PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.

J C Debruyne1, J Versijpt, K J Van Laere, F De Vos, J Keppens, K Strijckmans, E Achten, G Slegers, R A Dierckx, J Korf, J L De Reuck.   

Abstract

Activated microglia are involved in the immune response of multiple sclerosis (MS). The peripheral benzodiazepine receptor (PBR) is expressed on microglia and up-regulated after neuronal injury. [11C]PK11195 is a positron emission tomography (PET) radioligand for the PBR. The objective of the present study was to investigate [11C]PK11195 imaging in MS patients and its additional value over magnetic resonance imaging (MRI) concerning the immuno-pathophysiological process. Seven healthy and 22 MS subjects were included. Semiquantitative [11C]PK11195 uptake values were assessed with normalization on cortical grey matter. Uptake in Gadolinium-lesions was significantly increased compared with normal white matter. Uptake in T2-lesions was generally decreased, suggesting a PBR down-regulation. However, uptake values increased whenever a clinical or MR-relapse was present, suggestive for a dynamic process with a transient PBR up-regulation. During disease progression, an increase of normal-appearing white matter (NAWM) uptake was found, propagating NAWM as the possible real burden of disease. In conclusion, [11C]PK11195 and PET are able to demonstrate inflammatory processes with microglial involvement in MS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752399     DOI: 10.1046/j.1468-1331.2003.00571.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  85 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Decreased microglial activation in MS patients treated with glatiramer acetate.

Authors:  John N Ratchford; Christopher J Endres; Dima A Hammoud; Martin G Pomper; Navid Shiee; John McGready; Dzung L Pham; Peter A Calabresi
Journal:  J Neurol       Date:  2011-12-09       Impact factor: 4.849

Review 3.  Positron emission tomography imaging in neurological disorders.

Authors:  Marios Politis; Paola Piccini
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

Review 4.  Imaging of multiple sclerosis: role in neurotherapeutics.

Authors:  Rohit Bakshi; Alireza Minagar; Zeenat Jaisani; Jerry S Wolinsky
Journal:  NeuroRx       Date:  2005-04

5.  Translocator protein PET imaging for glial activation in multiple sclerosis.

Authors:  Unsong Oh; Masahiro Fujita; Vasiliki N Ikonomidou; Iordanis E Evangelou; Eiji Matsuura; Erin Harberts; Yota Fujimura; Nancy D Richert; Joan Ohayon; Victor W Pike; Yi Zhang; Sami S Zoghbi; Robert B Innis; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-09-25       Impact factor: 4.147

6.  Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography.

Authors:  Anne Roivainen; Kjell Någren; Jussi Hirvonen; Vesa Oikonen; Pauliina Virsu; Tuula Tolvanen; Juha O Rinne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

Review 7.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

8.  In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.

Authors:  Abraham Martín; Nuria Vázquez-Villoldo; Vanessa Gómez-Vallejo; Daniel Padro; Federico N Soria; Boguslaw Szczupak; Sandra Plaza-García; Ander Arrieta; Torsten Reese; Jordi Llop; Maria Domercq; Carlos Matute
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-10       Impact factor: 9.236

9.  The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.

Authors:  Sriram Venneti; Guoji Wang; Jason Nguyen; Clayton A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

10.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Authors:  Ulrike W Kaunzner; Yeona Kang; Shun Zhang; Eric Morris; Yihao Yao; Sneha Pandya; Sandra M Hurtado Rua; Calvin Park; Kelly M Gillen; Thanh D Nguyen; Yi Wang; David Pitt; Susan A Gauthier
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.